Hester Biosciences Q4 Results
- BSE: 524669
- NSE: HESTERBIO
- ISIN: INE782E01017
- Sector: Biotechnology & Drugs
BSE
1,942.15
-10.00 (-0.51%)
-10.00 (-0.51%)Volume286.00
Updated: Fri 12 Jun, 2026 | 15:28:27
NSE
1,952.90-7.00 (-0.36%)
-7.00 (-0.36%)Volume3.04 K
Updated: Fri 12 Jun, 2026 | 15:44:25
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹100.11 Cr.(22.20%)
- Operating Profit₹31.35 Cr.(108.96%)
- Profit After Tax₹15.98 Cr.(1137.96%)
- Operating Margin31.32%(71.00%)
Note: Comparison is on YoY basis
Quarterly - Hester Biosciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 68.76 | 64.05 | 7.34% | 67.08 | 2.74% |
| Depreciation/ Amortization | 5.91 | 4.43 | 33.47% | 3.74 | 41.62% |
| Operating Income | 31.35 | 13.36 | 134.65% | 12.18 | 108.96% |
| Net Income | 15.98 | 8.77 | 82.34% | 4.95 | 1137.96% |
| Other Operating Expenses Total | 29.96 | 23.38 | 28.17% | 25.69 | 7.73% |
| Net Income Before Taxes | 25.09 | 13.52 | 85.51% | 9.87 | 569.91% |
| Total Revenue | 100.11 | 77.41 | 29.32% | 79.26 | 22.20% |
| Selling/ General/ Admin Expenses Total | 16.37 | 15.52 | 5.46% | 16.10 | 15.33% |
| Diluted Normalized EPS | 17.09 | 10.94 | 56.25% | 4.98 | 1160.67% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.